Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,870.51
(
-1.65%
)
News Focus
News Focus
Post# of 517105
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4002
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: Alexander Rabe post# 496026

Sunday, 08/03/2025 1:10:50 PM

Sunday, August 03, 2025 1:10:50 PM

Post# of 517105
Yes. Blarcamesine does not move the clinical needle in 65%-75% of those patients but is a must have for 25%-35% of that population. Still huge numbers.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News